This article is a correction to:
A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol
Ming-Jer Chen1,2*†
Yu-Chiao Yi1,2†Hwa-Fen Guu1Ya-Fang Chen1Hsiao-Fan Kung1Jui-Chun Chang1Shih-Ting Chuan1Li-Yu Chen1- 1Department of Obstetrics and Gynecology and Women’s Health, Taichung Veterans General Hospital, Taichung, Taiwan
- 2School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
by Chen M-J, Yi Y-C, Guu H-F, Chen Y-F, Kung H-F, Chang J-C, Chuan S-T and Chen L-Y (2022) 13:931756. doi: 10.3389/fendo.2022.931756
In the published article, there was an error. Instead of “cumulative pregnancy rate”, it should be “cumulative live birth rate”.
A correction has been made to the Synopsis. This sentence previously stated:
“The cumulative pregnancy rate was significantly higher in the r-hFSH+r-hLH group (53% vs. 64%, p=0.02).”
The corrected sentence appears below:
“The cumulative live birth rate was significantly higher in the r-hFSH+r-hLH group (53% vs. 64%, p=0.02).”
In the published article, there was an error. Instead of “patients”, it should be “cycles”.
A correction has been made to Section 3 Results. The sentences previously stated:
“The cLBR of the patients included in the analysis is shown in Figure 2. There were 138 patients out of 259 achieved live births in Group 1 (cLBR = 53.3%), and 107 out of 166 in Group 2 (cLBR =64.5%).”
FIGURE 2
Figure 2 The cumulative live birth rate in Group 1 (rFSH+hMG) and Group 2 (rFSH+rLH). "*"represents statistical significance (p<0.05).
The corrected sentence appears below:
“The cLBR of the cycles included in the analysis is shown in Figure 2. There were 138 cycles out of 259 achieved live births in Group 1 (cLBR = 53.3%), and 107 out of 166 in Group 2 (cLBR =64.5%).”
In the published article, there was an error in Figure 2 as published. The y-axis title was marked “Cumulative pregnancy rate”. The corrected y-axis title of Figure 2 should be “Cumulative live birth rate”.
The corrected figure and its caption appear below:
The authors apologize for the errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: controlled ovarian hyperstimulation, recombinant FSH, recombinant LH, human menopausal gonadotrophin (hMG), pregnancy
Citation: Chen M-J, Yi Y-C, Guu H-F, Chen Y-F, Kung H-F, Chang J-C, Chuan S-T and Chen L-Y (2022) Corrigendum: A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol. Front. Endocrinol. 13:1099647. doi: 10.3389/fendo.2022.1099647
Received: 16 November 2022; Accepted: 22 November 2022;
Published: 07 December 2022.
Edited and Reviewed by:
Eleonora Porcu, University of Bologna, ItalyCopyright © 2022 Chen, Yi, Guu, Chen, Kung, Chang, Chuan and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ming-Jer Chen, mingjerchen@gmail.com
†These authors have contributed equally to this work and share first authorship